Get the Stockscreener App
0.26
5.69%
0.014
After Hours:
.25
-0.01
-3.85%
Biorestorative Therapies Inc stock is traded at $0.26, with a volume of 1.08M.
It is up +5.69% in the last 24 hours and down -14.16% over the past month.
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
See More
Previous Close:
$0.246
Open:
$0.246
24h Volume:
1.08M
Relative Volume:
0.12
Market Cap:
$6.62M
Revenue:
$359.70K
Net Income/Loss:
$-14.24M
P/E Ratio:
-0.1588
EPS:
-1.6376
Net Cash Flow:
$-10.91M
1W Performance:
+1.25%
1M Performance:
-14.16%
6M Performance:
-83.75%
1Y Performance:
-85.39%
1-Day Range:
$0.246
$0.2643
1-Week Range:
$0.24
$0.2643
52-Week Range:
$0.19
$2.045
Biorestorative Therapies Inc Stock (BRTX) Company Profile
Name
Biorestorative Therapies Inc
Sector
Industry
Phone
(631) 760-8100
Address
40 MARCUS DRIVE, MELVILLE
Compare BRTX vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
0.26 | 6.27M | 359.70K | -14.24M | -10.91M | -1.6376 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Biorestorative Therapies Inc Stock (BRTX) Latest News
Huge share increase and Nasdaq bid warning for BioRestorative (BRTX) - Stock Titan
Biorestorative Therapies, Inc. (BRTX) reports Q4 loss, lags revenue estimates - MSN
Movement Recap: Is BioRestorative Therapies Inc stock a hidden gemDividend Hike & Step-by-Step Swing Trade Plans - baoquankhu1.vn
Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates - MSN
Analyst Upgrade: Is BioRestorative Therapies Inc still a buy after recent gainsInsider Selling & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform - Sahm
BioRestorative Therapies, Inc. Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform - marketscreener.com
BioRestorative partners with 203 Creates for skincare brand launch By Investing.com - Investing.com Canada
BioRestorative partners with 203 Creates for skincare brand launch - Investing.com
BioRestorative Therapies Announces Strategic Collaboration with 203 Creates - National Today
BRTX.O Technical Analysis & Stock Price Forecast - Intellectia AI
Aug EndMonth: Is BioRestorative Therapies Inc undervalued by DCF analysisWeekly Trading Summary & Safe Capital Growth Plans - baoquankhu1.vn
BRTX SEC FilingsBiorestorative Therapies Inc 10-K, 10-Q, 8-K Forms - Stock Titan
BioRestorative Therapies (BRTX) seeks 1.5B-share authorization ahead of May 26 vote - Stock Titan
BRTX Technical Analysis & Stock Price Forecast - Intellectia AI
Dow Update: Whats the beta of BioRestorative Therapies Inc stock2026 Sector Moves & Expert-Curated Trade Recommendations - baoquankhu1.vn
BRTX Stock Price, Quote & Chart | BIORESTORATIVE THERAPIES INC (NASDAQ:BRTX) - ChartMill
Loss Report: Is BioRestorative Therapies Inc undervalued by DCF analysis2026 Market Overview & Verified Entry Point Detection - baoquankhu1.vn
Dip Buying: Whats the MACD signal for BioRestorative Therapies Inc2026 Reactions & Expert Curated Trade Ideas - baoquankhu1.vn
Published on: 2026-03-31 07:08:56 - baoquankhu1.vn
US Stocks Recap: Will BioRestorative Therapies Inc stock go up in YEARRisk Management & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn
Chipmakers Recap: Does Cybin Inc stock have upside surprise potentialCPI Data & Low Risk High Win Rate Picks - baoquankhu1.vn
Biorestorative Therapies reports positive phase 2 blinded data for brtx-100 - marketscreener.com
Biorestorative Therapies Reports Positive Phase 2 Blinded Data For Brtx-100 - TradingView
BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease - bitget.com
BioRestorative Therapies Reports Positive Phase 2 Blinded - GlobeNewswire
Volatility Watch: Will BioRestorative Therapies Inc stock go up in YEAR2026 Price Momentum & Daily Stock Trend Watchlist - baoquankhu1.vn
BioRestorative Therapies earnings beat by $0.01, revenue fell short of estimates - Investing.com
BioRestorative Therapies (OTCMKTS:BRTXQ) Stock Price Down 4.5%Here's What Happened - MarketBeat
Published on: 2026-03-28 23:31:57 - baoquankhu1.vn
Biorestorative Therapies, Inc. (BRTX) Announces Fourth Quarter Loss, Falls Short of Revenue Projections - Bitget
BIORESTORATIVE THERAPIES ($BRTX) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative
BioRestorative Therapies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Biorestorative Therapies, Inc. (BRTX) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
BioRestorative Therapies 10-K: $0.36M Revenue, $(14.24)M Net Loss - TradingView
BioRestorative (NASDAQ: BRTX) advances BRTX-100 program and raises capital - Stock Titan
BioRestorative Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Published on: 2026-03-26 20:00:53 - baoquankhu1.vn
BioRestorative Therapies, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Hedge Fund Bets: Is BioRestorative Therapies Inc still a buy after recent gainsEarnings Summary Report & Fast Moving Stock Trade Plans - baoquankhu1.vn
BioRestorative Therapies Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView
If You Invested $1,000 in Biorestorative Therapies Inc (BRTX) - Stock Titan
Bull Run: Whats the beta of BioRestorative Therapies Inc stock2026 Technical Overview & Expert Curated Trade Ideas - baoquankhu1.vn
Published on: 2026-03-22 01:59:34 - baoquankhu1.vn
Quarterly Trades: Will BioRestorative Therapies Inc stock benefit from M A2026 Technical Patterns & Weekly Stock Performance Updates - baoquankhu1.vn
Published on: 2026-03-21 10:51:08 - baoquankhu1.vn
Biorestorative Therapies Inc Stock (BRTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):